Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis
JHEP Reports · 2026-12 · 8 (12) · 102003
DOI: 10.1016/j.jhepr.2026.102003 ↗Kurz gefasst
Fachartikel in der Zeitschrift JHEP Reports, 2026-12. Verfasst von Ainhoa Lapitz und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, San Sebastian, Spain; Nation…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cholangiocarcinoma Foundation, Horizon 2020 Framework Programme, Eusko Jaurlaritza.
Abstract (Originalsprache)
BACKGROUND & AIMS: Cholangiocarcinoma (CCA) is a major complication of primary sclerosing cholangitis (PSC), with a 20-year incidence of ∼15%. Early detection is challenging, as current surveillance rarely identifies CCA at a resectable stage. This study investigated bile-derived extracellular vesicles (EVs) as a liquid biopsy source for protein biomarkers enabling early diagnosis and prediction of CCA in PSC. METHODS: Bile samples were collected from PSC (n = 52), PSC with concomitant CCA (PSC-CCA; n = 14), and patients with PSC who later developed CCA (PSC to CCA; n = 8). EV proteomes were analyzed by mass spectrometry. Multivariable logistic regression models were used to evaluate diagnostic performance. Biomarker expression was assessed in CCA single-cell RNA sequencing (scRNA-seq) datasets, and selected proteins were validated in total serum by ELISA. RESULTS: Proteomic analysis identified 15 EV proteins that distinguished PSC-CCA from PSC independently of demographic and clinical factors. A four-protein machine learning model (COPA, ATP5H, VTNC, and PRDX2) combined with serum CA19-9 achieved high diagnostic performance for PSC-CCA in our cohort (AUC = 0.993), outperforming CA19-9 alone (AUC = 0.801). A separate three-protein panel (TM9S4, ATPO, and KINH) showed potential for early identification of patients with PSC who later developed CCA, before clinical or radiological detection, with an internally estimated sensitivity of 100% and specificity of 97%, whereas CA19-9 showed no predictive value. COPA, VTNC, and PRDX2 were validated in total serum by ELISA, and scRNA-seq supported the expression of these markers in malignant cholangiocytes. CONCLUSIONS: Bile EVs contain protein biomarkers with promising diagnostic value and potential utility for risk stratification of future CCA development in individuals with PSC. Pending further external validation, as bile collection may be performed during routine ERCP procedures, this liquid biopsy approach could facilitate earlier detection, timely interventions, and improved outcomes. IMPACT AND IMPLICATIONS: PSC-associated CCA remains a major clinical challenge, burdened by ineffective surveillance strategies and poorly sensitive diagnostic tools. This exploratory study identifies bile EV protein signatures with promising diagnostic performance and potential value for short-term risk stratification or early detection, including biomarker panels that enhance standard CA19-9 performance and detect malignancy prior to clinical or radiological diagnosis. The detectability of some of these biomarkers by ELISA supports their technical feasibility and potential clinical applicability. These findings require validation in larger, independent cohorts before clinical implementation can be considered; if externally validated, bile EV-based biomarkers may represent a complementary tool during routine ERCP procedures, potentially supporting earlier identification of curative treatment candidates and strengthening the rationale for bile-based liquid biopsy approaches in PSC-associated CCA surveillance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, San Sebastian, Spain; National Institute for the Study of Liver and Gastrointestinal Diseases (CIB…
- Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway; Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway; Research Institute of Internal Medicine, Oslo University Hosp…
- Department of Liver and Gastrointestinal Diseases, Biogipuzkoa Health Research Institute - Donostia University Hospital, San Sebastian, Spain; Department of Surgery, Oncology and Gastroenterology, University of Padova,…
- National Institute for the Study of Liver and Gastrointestinal Diseases (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain; Proteomics Platform, CIC bioGUNE, Basque Research & Technology Alliance (BRTA), Derio, Sp…
- Norwegian PSC Research Center, Oslo University Hospital, Oslo, Norway; Department of Clinical Science, University of Bergen, Bergen, Norway; Haraldsplass Deaconess Hospital, Bergen, Norway.
- Department of Pathology, Oslo University Hospital, Oslo, Norway.
Förderung
- Cholangiocarcinoma Foundation
- Horizon 2020 Framework Programme
- Eusko Jaurlaritza
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas
- Ministerio de Ciencia, Innovación y Universidades
- Diputación Foral de Gipuzkoa
- Instituto de Salud Carlos III
- Fundación Científica Asociación Española Contra el Cáncer
Zitieren
APA
Lapitz, A., Grimsrud, M. M., Catanzaro, E., Rodrigues, P. M., Hov, J. R., Azkargorta, M., Val, B., Vesterhus, M., Grzyb, K., Reims, H. M., Elortza, F., Izquierdo-Sanchez, L., Perugorria, M. J., Bujanda, L., Aabakken, L., Paulsen, V., Karlsen, T. H., Banales, J. M., & Folseraas, T. (2026). Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis. JHEP Reports, 8(12), 102003. https://doi.org/10.1016/j.jhepr.2026.102003
Vancouver
Lapitz A, Grimsrud MM, Catanzaro E, Rodrigues PM, Hov JR, Azkargorta M, et al. Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis. JHEP Reports. 2026;8(12):102003. doi:10.1016/j.jhepr.2026.102003
BibTeX
@article{Lapitz2026,
author = {Lapitz, Ainhoa and Grimsrud, Marit M and Catanzaro, Elisa and Rodrigues, Pedro M and Hov, Johannes R and Azkargorta, Mikel and Val, Beatriz and Vesterhus, Mette and Grzyb, Krzysztof and Reims, Henrik Mikael and Elortza, Felix and Izquierdo-Sanchez, Laura and Perugorria, María J and Bujanda, Luis and Aabakken, Lars and Paulsen, Vemund and Karlsen, Tom H and Banales, Jesus M and Folseraas, Trine},
title = {Bile extracellular vesicles for early cholangiocarcinoma detection in primary sclerosing cholangitis},
journal = {JHEP Reports},
year = {2026},
volume = {8},
number = {12},
pages = {102003},
doi = {10.1016/j.jhepr.2026.102003}
}
EUVIMED